- FDA approved: Yes (First approved December 28th, 2012)
- Brand name: Sirturo
- Generic name: bedaquiline
- Company: Janssen Research & Development, LLC
- Treatment for: Tuberculosis, Resistant
Sirturo (bedaquiline) is an oral diarylquinoline antimycobacterial drug indicated for the treatment of pulmonary multi-drug resistant tuberculosis.
No comments:
Post a Comment